ORAMED PHARMACEUTICALS INC. Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31)
ORAMED PHARMACEUTICALS INC. (ORMP) had Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) of $1.06 million as of 2012-11-30, per its 10-Q filed 2012-12-26.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesFairValueDisclosure · last filed 2012-12-26
- 2012-11-30: Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) $1.06M.
- 2012-08-31: Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) $200.31K.
- 2011-08-31: Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) $384.56K.
| Period end | Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) |
|---|---|
| 2012-11-30 | $1.06M 10-Q · filed 2012-12-26 |
| 2012-08-31 | $200.31K 10-Q · filed 2012-12-26 |
| 2011-08-31 | $384.56K 10-K · filed 2012-12-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |